LSL Pharma Group Inc Class A LSL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.44
- Day Range
- CAD 0.43–0.46
- 52-Week Range
- CAD 0.35–0.55
- Bid/Ask
- CAD 0.45 / CAD 0.46
- Market Cap
- CAD 51.41 Mil
- Volume/Avg
- 46,315 / 21,104
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.laboratoirelsl.com
Valuation
|
Metric
|
LSL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.60 |
Price/Sales | 2.76 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LSL
|
|---|---|
Quick Ratio | 0.38 |
Current Ratio | 1.06 |
Interest Coverage | −0.15 |
Quick Ratio
LSL
Profitability
|
Metric
|
LSL
|
|---|---|
Return on Assets (Normalized) | −7.14% |
Return on Equity (Normalized) | −18.44% |
Return on Invested Capital (Normalized) | −1.93% |
Return on Assets
LSL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Xgyzjqcxj | Ygql | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Xtzvlnrchh | Gfdlhc | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Zlkfqbvkx | Ksnjy | $48.4 Bil | |||
| Viatris Inc
VTRS
| Bfpltwdm | Psbnk | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Gsrtznq | Lfnx | $13.5 Bil | |||
| Catalent Inc
CTLT
| Stbzfcmz | Fhjztyj | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Mwzjygp | Sbfmkcs | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Xjjbvhb | Htzfs | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Fztlyvqxxw | Swvg | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Mfyvzrf | Ylngs | $2.3 Bil |
United States